Table 4.
Group | NCEP-ATPIII metabolic syndrome positive | IDF metabolic syndrome positive | p-Value |
---|---|---|---|
Study Group, n (%) | 34/86 (39.5%) | 35/86 (40.7%) | <0.001 |
Control Group, n (%) | 10/115 (8.7%) | 18/115 (15.6%) | <0.001 |
NCEP-ATPIII, National Cholesterol Education Program Adult Treatment Panel III; IDF, The International Diabetes Federation.